Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Dennis Joiner

Advertisement

Articles by Dennis Joiner

Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)

ByRichard Creekmore,Amnon Eylath,John W. Skoug,Jackson Pellett,Michael Lovdahl,Dennis Joiner,Eleni Dokou,Eric Schmitt
August 2nd 2012

IQ Consortium representatives explore industry approaches and practices for applying GMPs in early development.

Advertisement

Latest Updated Articles

  • Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)
    Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)

    August 2nd 2012



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

2

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

3

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

4

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

5

Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us